Patients are at the centre of OICR’s research strategy, which fosters an integrated translational research pathway that links cancer discoveries to patient impact.
In collaboration with our partners, we focus on developing the knowledge and tools to implement next-generation cancer precision medicine in Ontario.
For patients, this contributes to better cancer prevention, detection, diagnosis and treatment. Ultimately, this leads to improved patient survival and quality of life while also providing economic benefits for the people of Ontario.
Our overall research strategy is guided by these five overarching goals:
Advance early detection and intervention research
Reinforce Ontario’s global leadership in data sharing and analytics
Expand a robust pipeline of novel cancer therapeutics
Drive the translation and commercialization of cancer innovations in Ontario
Strengthen and sustain Ontario’s capacity for translational cancer research
OICR conducts and facilitates research tackling cancer from multiple angles. Our efforts are grouped into three integrated themes:
Developing knowledge and approaches to detect and monitor cancer over its life cycle to enable precise and proactive clinical management.
Advancing Ontario cancer discoveries through early clinical validation, partnering with industry and the health system for downstream development and implementation of new treatments, diagnostics and biomarkers, thus fostering precision medicine for cancer patients.
Validating novel cancer drug targets and advancing select therapeutic candidates towards clinical development.
OICR enables world-class translational cancer research in Ontario.
Recruiting, developing and engaging outstanding Ontario cancer researchers and clinician-scientists.
Providing access to cutting-edge research tools, assays, databases, expertise, resources and infrastructure.
Supporting activities that promote the uptake of evidence-based practice and research into regular use by policymakers and healthcare providers.
Cancer is incredibly complex, so tackling it requires a team effort. Collaborative research is critical for maximizing the impact of our investment and achieving breakthroughs in patient care.
OICR actively collaborates with both the private and public sector, including pharmaceutical companies, biotechnology companies, venture capital firms, cancer centres, research institutes, hospitals, government agencies, academia and patients.
OICR investigators collaborate with the oncology research community in Ontario, across Canada and around the world.
Visit our Collaborative Research Resources directory, explore our programs or meet our researchers to find out more about opportunities to collaborate.